Get Quote: MCK
Financials: Latest Results
The nation's largest health-care provider greatly expanded its already extensive cancer treatment business when it bought U.S. Oncology for $2.2 billion last December. Still, distribution remains McKesson's backbone: A full one-third of all medicines used in the U.S. run through its pipeline.
Subscribe to Fortune Magazine
The company also is the dominant player in health care information systems. More than 70% of the nation's big market hospitals use its technology to digitize prescriptions and patient medical records. A class-action lawsuit over wholesale drug prices has cut into profits; still, its stock is up 23% over the past year. --P.N. Is McKesson a great company, or what?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Industry: Wholesalers: Health Care
|
Fortune 500+ Web app
Galleries and more
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rank # of Fortune 500 Companies | |
|---|---|
| New York | 57 |
| California | 53 |
| Texas | 51 |
| Company | Rank |
|---|---|
| Microsoft | 38 |
| Goldman Sachs | 54 |
| Intel | 56 |
| Company | 2010 $ (millions) |
|---|---|
| Exxon Mobil | $30,460.0 |
| AT&T | $19,864.0 |
| Chevron | $19,024.0 |
.
